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Abstract
Background: The type I interferon (IFN) response is a critical component of the innate immune response to
infection by RNA viruses and is initiated via recognition of viral nucleic acids by RIG-like receptors (RLR).
Engagement of these receptors in the cytoplasm initiates a signal transduction pathway leading to activation
of the transcription factors NF-κB, ATF-2 and IRF-3 that coordinately upregulate transcription of type I IFN
genes, such as that encoding IFN-β. In this study the impact of poliovirus infection on the type I interferon
response has been examined.
Methods: The type I IFN response was assessed by measuring IFN-β mRNA levels using qRT-PCR and
normalizing to levels of β-actin mRNA. The status of host factors involved in activation of the type I IFN
response was examined by immunoblot, immunofluorescence microcopy and qRT-PCR.
Results: The results show that poliovirus infection results in induction of very low levels of IFN-β mRNA
despite clear activation of NF-κB and ATF-2. In contrast, analysis of IRF-3 revealed no transcriptional induction
of an IRF-3-responsive promoter or homodimerization of IRF-3 indicating it is not activated in poliovirus-infected
cells. Exposure of poliovirus-infected cells to poly(I:C) results in lower levels of IFN-β mRNA synthesis and IRF-3
activation compared to mock-infected cells. Analysis of MDA-5 and IPS-1 revealed that these components of the
RLR pathway were largely intact at times when the type I IFN response was suppressed.
Conclusions: Collectively, these results demonstrate that poliovirus infection actively suppresses the host type
I interferon response by blocking activation of IRF-3 and suggests that this is not mediated by cleavage of
MDA-5 or IPS-1.
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Introduction
Picornaviruses are small, positive sense, single-stranded
RNA viruses belonging to the family Picornaviridae. The
Picornaviridae now consists of nearly 30 different genera
representing a diverse group of virus pathogens that
cause disease in humans and animals. One of the most
studied genera in this family is that of the Enterovirus
which includes poliovirus, rhinovirus and coxsackievirus
among others. Following release of viral RNA into the
cytoplasm the viral genome is translated into a single
polyprotein, which is proteolyzed to produce individual
viral proteins responsible for RNA synthesis, assembly
and modulation of host cell functions. RNA synthesis is
carried out by the virus-encoded RNA-dependent RNA
polymerase that first transcribes the plus-strand to pro-
duce a double stranded RNA (dsRNA) consisting of full
length plus and minus-strand RNAs and known as the
replicative form (RF-RNA). Newly synthesized minus-
strands serve as a template for plus-strand synthesis and
result in the appearance of full length plus-strands along
with replicative intermediates consisting of incomplete
plus strands partially annealed with the minus strand
(Reviewed in [1]).
Recognition of viral RNA species in infected cells results
in the transcriptional activation of the Type I interferon
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(IFN) response. Viral dsRNA is recognized by membrane
bound and cytosolic cellular pattern recognition receptors.
Cytosolic receptors include the RIG-like-Receptors, RIG-I
and MDA-5 that signal through the adapter protein IPS-1
(also known as Cardiff, VISA or MAVS) (Reviewed in [2]).
Membrane bound receptors include the Toll-like receptor,
TLR3, which recognizes dsRNA in the endosomal com-
partment (Reviewed in [3]). Activation of RLRs and TLRs
initiates distinct signaling pathways that converge on the
cellular transcription factors NF-κB, IRF-3 and ATF-2
which are required for the induction of IFN-β mRNA and
the type I interferon response [4]. Secreted IFN-β binds to
the type I IFN receptor to activate the Jak/STAT signaling
pathway [5] resulting in the production of a variety of pro-
teins having antiviral, immunomodulatory and antiprolif-
erative functions [6].
The RIG-like-receptor (RLR) Melanoma differentiation-
associated gene 5 (MDA-5) is thought to be critical for the
recognition of picornavirus RNA based on the observation
that mice lacking MDA-5 are more susceptible to enceph-
alomyocarditis virus, another picornavirus [7, 8]. Subse-
quent work using siRNA knockdown or mouse embryonic
fibroblasts lacking MDA-5 has shown that recognition of
the double stranded RF-RNA is critical for induction of
type I IFN in tissue culture [9–11]. More recent work
found that TLR3 plays an important role in modulating
the host response to poliovirus-infection in a transgenic
mouse model [12, 13]. Thus, it appears that multiple path-
ways may contribute to limiting pathogenesis associated
with enterovirus infections.
Work done in the late 1950s showed that poliovirus
replication is sensitive to the antiviral effects of type I
interferon in tissue culture [14]. More recent work in
transgenic mice expressing the poliovirus receptor,
CD155, has extended these finding by showing that the
type I interferon response plays a critical role in control-
ling disease progression by inhibiting replication in non-
neural tissue and preventing spread to the central ner-
vous system [15, 16]. While these findings indicate that
IFN may be effective against poliovirus, more recent
work has shown that poliovirus can overcome the inhibi-
tory effects of this antiviral cytokine. For example, polio-
virus can replicate in tissue culture cells exposed to low
doses of interferon and this is dependent upon activities
provided by the virus 2A protease [17].
In addition to overcoming the antiviral effects of IFN,
several findings suggest that poliovirus inhibits pathways
leading to the initial synthesis of IFN-β. Although entero-
virus RF-RNA is a potent activator of IFN-β synthesis
when transfected into cells [9, 10] very little IFN-β is actu-
ally made in poliovirus, or other enterovirus-infected cells
suggesting that activation of this pathway may be impaired
[18–22]. Also in support of this possibility is the finding
that little or no activated IRF-3 is detected in cells infected
with rhinovirus, enterovirus71 or coxsackievirus B3
[19–23]. Furthermore, both human rhinovirus 1a and cox-
sackievirus B3 block the ability of sendai virus to activate
IRF-3 indicating that these enteroviruses can actively sup-
press induction of the type I IFN response pathway [20,
21]. An explanation for these findings was provided by the
observation that RIG-I, MDA-5 and IPS-1 are proteolyzed
during infection with these viruses [21–25]. MDA-5, RIG-
I and IPS-1 are also proteolyzed in poliovirus-infected
cells [21, 24, 25] although the status of the type I IFN
response pathway has not been examined.
To address this, we have examined the induction of IFN-
β mRNA and the activation status of NF-κB, IRF-3 and
ATF-2 in poliovirus-infected cells. The results demonstrate
that poliovirus infection results in the activation of both
ATF-2 and NF-κB but very little activation of IRF-3. In
addition, the ability of infected cells to synthesize IFN-β
mRNA in response to stimulation with poly(I:C) is im-
paired indicating that the type I IFN response is suppressed.
Surprisingly, inhibition occurs before significant degrad-
ation of NF-κB, MDA-5 or IPS-1 is apparent in infected
cells. These results suggest that poliovirus, and perhaps
other enteroviruses, may target additional host factors to
mediate inhibition of the host type I interferon response.
Results
Poliovirus infection fails to activate the type I IFN response
Το examine the status of the type I IFN response fol-
lowing infection with poliovirus we selected HEC-1B
cells. HEC-1B cells are non-responsive to interferon
due to the lack of functional IFNα/ IFNβ receptors
[26, 27]. Consequently the induction of type I inter-
feron in this cell line is entirely due to the infecting
virus and independent of autocrine or paracrine sig-
naling that would further amplify the cellular re-
sponse. Prior work using RNase protection assays had
reported little accumulation of IFN-β mRNA in HEC-
1B cells following infection [18]. To quantitatively as-
sess IFN-β mRNA levels in poliovirus-infected HEC-
1B cells RNA was isolated and analyzed by qRT-PCR.
Poliovirus-infected cells showed only a 2 fold increase
in IFN-β mRNA levels at 3 and 4 h post infection
(hpi) and by 5 hpi levels were very similar to mock-
infected controls (Fig. 1). As a positive control we
treated the cells with poly(I:C), a synthetic analogue
of double-stranded RNA (dsRNA) and a known in-
ducer of IFN-β mRNA and the type I IFN response
[28]. Figure 1 shows that poly(I:C) treatment of HEC-
1B cells resulted in greater than 300 fold induction of
IFN-β mRNA compared to the mock-infected con-
trols. In agreement with other reports, low levels of
IFN-β mRNA were also observed in poliovirus-
infected HeLa cells, although levels were higher com-
pared to what was observed in poliovirus-infected
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HEC-1B cells, perhaps due to amplification via the
Jak/STAT pathway (data not shown) [24, 29]. Polio-
virus RNA levels increased by 4 logs from 1 to 5 hpi
confirming active replication in this cell line as re-
ported by Dodd et al. ([18] and data not shown).
These results demonstrate that poliovirus infection
does not induce a strong type I interferon response
in either HeLa or HEC-1B cells.
Poliovirus infection inhibits the ability of cells to respond
to dsRNA
The lack of induction of IFN-β mRNA in poliovirus-
infected cells indicates that the virus might interfere
with the activation of this host defense signaling
pathway. Consistent with this possibility, Dodd and
Kirkegaard used RNase protection assays to show that
poliovirus inhibits the ability of cells to produce IFN-
β mRNA in response to treatment with poly(I:C) [30].
To further validate and quantify the extent of inhibition,
we have analyzed IFN-β mRNA levels in poliovirus-
infected cells treated with poly(I:C) by qRT-PCR. Pre-
vious studies have shown that poliovirus infection be-
gins to inhibit host cell transcription at ~3 hpi with
maximal inhibition not occurring until 5 hpi [31, 32].
Hence, we have conducted these experiments at early
times following infection to reduce complications
from poliovirus-mediated host transcriptional shut off.
The strategy used for this analysis is outlined in
Fig. 2a. Briefly, HEC-1B cells were infected with
poliovirus and then treated with poly(I:C) at 1.5 h
post-infection. RNA was isolated after an additional
1.5 or 2.5 h (3 and 4 hpi, respectively) and the levels
of IFN-β mRNA were determined. When uninfected
cells were treated with poly(I:C) IFN-β mRNA was in-
duced 40-fold after 1.5 h and 305-fold after 2.5 h
(Fig. 2b). However, if cells were first infected with
poliovirus and then treated with poly(I:C) the level of
induction after 1.5 h (3 hpi) was only 6-fold and after
2.5 h (4 hpi) only 55-fold. Quantification of these re-
sults revealed that poliovirus inhibited the amount of
IFN-β mRNA produced in response to poly(I:C) treatment
for 1.5 and 2.5 h by 85 % and 82 %, respectively. Since
poliovirus inhibits host cell transcription by only 35 % at 3
hpi this inhibition is likely not entirely due to the host
transcriptional shut off in infected cells. Although polio-
virus infection results in the inhibition of host protein syn-
thesis, previous studies have indicated that de novo
protein synthesis is not required for the induction of
IFN-β mRNA [33]. This indicates that the poliovirus-
mediated inhibition of IFN-β induction is not likely
due to host translational shutoff and suggests that
poliovirus infection specifically inhibits the ability of
cells to sense and/or respond to dsRNA.
Status of ATF-2 and NF-κB in poliovirus-infected cells
Transcriptional induction of the IFN-β promoter re-
quires the coordinated action of the activated transcrip-
tion factors ATF-2, NF-κB and IRF-3. To determine the
reason for the lack of induction of IFN-β mRNA in
poliovirus-infected cells the status of these transcription
factors was analyzed.
ATF-2 resides in the nucleus at steady state and fol-
lowing activation gets phosphorylated on two threonine
residues [34]. To determine if ATF-2 is activated in
poliovirus-infected cells a phospho-specific antibody that
recognizes activated ATF-2 was used. As expected, very
little phospho-ATF-2 was present in mock-infected cells
consistent with ATF-2 being in an inactivated state
(Fig. 3a, lane 1). Following infection the amount of
phospho-ATF-2 was elevated at 4 hpi and continued to
increase through 6 hpi (Fig. 3a, lanes 2–4). These results
indicate that ATF-2 is intact and activated in poliovirus-
infected cells.
NF-κB normally resides in the cytoplasm, but fol-
lowing infection by many viruses NF-κB is activated
and rapidly accumulates in the nucleus [35, 36].
Neznanov et al., found that NF-κB is activated fol-
lowing infection by poliovirus and then subsequently de-
graded [37]. Thus it was possible that proteolysis of
NF-κB might be responsible for the lack of IFN- β
transcription in poliovirus-infected cells. Conse-
quently, we examined the sub-cellular localization and
the steady state levels of NF-κB in poliovirus-infected
Fig. 1 Poliovirus infection fails to induce a type I interferon response in
HEC-1B cells. Total RNA extracted from uninfected, poliovirus-infected or
poly(I:C) treated cells at the indicated times post-infection was analyzed
by qRT-PCR with primers for both IFN-β and β-actin mRNA. The amount
of IFN-βmRNA was normalized to the amount of β-actin mRNA. The fold
induction of IFN-β mRNA relative to uninfected controls is shown. Error
bars indicate the standard error of the results from triplicate wells. hpi:
hours post infection
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HEC-1B cells. Figure 3b shows that, as expected,
NF-κB is cytoplasmic in mock-infected cells and that
by 3 hpi and 4 hpi it is predominantly nuclear, sug-
gesting that NF-κB is activated in HEC-1B cells fol-
lowing infection with poliovirus. To determine if
NF-κB is cleaved in poliovirus-infected HEC-1B cells,
steady state levels of the protein were examined. Im-
munoblot analysis shows that although proteolysis is
apparent at 4 hpi there is still a significant amount
of intact NF-κB remaining in infected cells at this
time (Fig. 3c, lanes 2). Even at an MOI of 100 NF-κB levels
were unchanged at 3 hpi although levels had declined
significantly by 4 and 5 hpi (Fig. 3c, lanes 5–7). These
results are in agreement with the previously published
analysis of NF-κB in poliovirus-infected HeLa cells
[37]. The finding that NF-κB is predominantly nuclear
and is mostly intact at 3 hpi suggests that inhibition
of the type I IFN response is not due to proteolysis
of this transcription factor.
Poliovirus infection fails to activate IRF-3
To determine if IRF-3 is transcriptionally active in
poliovirus-infected cells we have examined the in-
duction of interferon stimulated gene 54 (ISG54), an
IRF-3 responsive transcript [38]. Figure 4a shows
that the levels of ISG54 mRNA in poliovirus-
infected cells were very similar to the mock-infected
controls even at 4 and 5 hpi. In contrast, poly(I:C),
an inducer of IRF-3 and the type I IFN response re-
sulted in a significant induction of ISG54. The low
levels of IFN-β and ISG54 mRNAs, suggest that IRF-
3 activation may be impaired in poliovirus-infected
cells.
Transcriptional activation by IRF-3 requires phos-
phorylation of S/T residues located in the C-terminus
leading to nuclear translocation and dimerization [39].
Consequently, the dimerization status of IRF-3 was
determined in poliovirus-infected cells by native
PAGE followed by immunoblot. Separation of lysates
on non-denaturing PAGE allows differentiation be-
tween the dimeric activated and monomeric inactive
forms of IRF-3 [40]. As expected, dimeric IRF-3 was
not seen in mock-infected cells, but was readily de-
tected following poly(I:C) treatment for 3.5 h (Fig. 4b,
lanes 1 and 6). Analysis of lysates from poliovirus-
infected cells failed to reveal detectable IRF-3 homo-
dimer even at 5 and 6 hpi (Fig. 4b, lanes 4 and 5).
The lack of induction of ISG54 and IFN-β mRNA
Fig. 2 Poliovirus infection inhibits the ability of cells to respond to dsRNA. a. Schematic outlining the experimental design. At zero hours cells
were either mock infected or infected with poliovirus at an MOI of 100 and 1.5 h later either treated or not with poly(I:C). After another 1.5 h
(3 hpi) or 2.5 h (4 hpi) RNA was extracted for analysis by qRT-PCR. b. IFN-β mRNA levels in poliovirus-infected HEC-1B cells treated as described
above. Total RNA was isolated and analyzed by qRT-PCR for IFN-β mRNA and normalized to levels of β-actin mRNA. The fold induction of IFN-β
mRNA relative to uninfected controls is shown. Error bars indicate the standard error of the results from triplicate wells. hpi: hours post infection
Kotla and Gustin Virology Journal  (2015) 12:158 Page 4 of 12
along with undetectable IRF-3 dimer suggests that
IRF-3 is not activated in poliovirus-infected cells.
Poliovirus infection inhibits poly(I:C) induced IRF-3
activation
Several picornaviruses, including enteroviruses have
been shown to inhibit activation of IRF-3 in response to
exogenous stimuli [20, 21, 41]. As the results of Fig. 2b
indicated that poliovirus can inhibit the cellular response
to poly(I:C), we wanted to determine if this might be
attributed to a viral blockade of IRF-3 activation. To
see if this was the case, IRF-3 dimerization was
assayed in lysates from poliovirus-infected cells that
had been treated with poly(I:C). As expected there
was good induction of IRF-3 dimer in uninfected cells
treated with poly(I:C) for 1.5 or 2.5 h (Fig. 5, lanes 4
Fig. 3 ATF-2 and NF-κB are activated in poliovirus-infected cells. a. Phosphorylation of ATF-2. Whole cell lysates prepared from uninfected or
poliovirus-infected cells were analyzed by immunoblotting. Phosphorylated ATF-2 (phospho-ATF-2) was detected by using an antibody specific
for the phosphorylated form of ATF-2. The membrane was also probed with an antibody to β-actin to show equivalent loading of protein lysates.
b. Subcellular localization of NF-κB. Cells that were mock-infected or had been infected with poliovirus for the indicated amount of time
were analyzed by immunofluorescence with antibodies to detect the p65 subunit of NF-κB. Panels labeled NF-κB show cells stained with
a rabbit polyclonal antibody to detect the p65 subunit of NF-κB using TRITC filter, while the panels labeled DNA show the same fields
stained with Hoechst to reveal the nuclei. c. Steady state levels of NF-κB. Whole cell lysates prepared from uninfected or poliovirus-infected cells at an
MOI 50 (lanes 2–4) or 100 (lanes 5–7) were analyzed by immunoblotting. The p65 subunit of NF-κB was detected by probing the membrane using
antibody specific for p65. The membrane was also probed with an antibody to β-actin to show equivalent loading of protein lysates. Arrows indicate
cleavage products produced following infection. hpi: hours post infection
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and 7) and IRF-3 dimer was undetectable in cells in-
fected with poliovirus (Fig. 5, lanes 2 and 5). Analysis
of cells infected and then treated with poly(I:C) re-
vealed that although IRF-3 homodimers were de-
tected, their levels were reduced compared to cells
treated with poly(I:C) alone (Fig. 5, compare lane 3
with 4 and lane 6 with 7). These results suggest that
the inhibition of IFN-β mRNA production observed
in poliovirus-infected cells treated with poly(I:C) may
be mediated by disrupting IRF-3 activation.
Status of MDA-5 and IPS-1 in poliovirus-infected cells
Prior studies have suggested that enteroviruses can
disrupt the activation of IRF-3 by causing the degrad-
ation of key signaling molecules such as MDA-5 and
IPS-1 that are required for its activation [20–25].
Analysis of poliovirus-infected HeLa cells cells found
that proteolysis of MDA-5 and IPS-1 was not appar-
ent until 4 hpi or later [21, 24], making it possible
that proteolysis of MDA-5 and IPS-1 occurs after the
inhibition of the type I IFN response reported here.
Fig. 4 IRF-3 is not activated in poliovirus-infected cells. a. ISG54 mRNA levels in infected cells. Total RNA extracted from uninfected,
poliovirus-infected or poly(I:C) treated cells at the indicated times post-infection was analyzed by qRT-PCR with primers for both interferon
stimulated gene 54 (ISG54) and β-actin mRNAs. The amount of ISG54 mRNA was normalized to the amount of β-actin mRNA. The fold induction of
ISG54 mRNA relative to uninfected controls is shown. Error bars indicate the standard error of the results from triplicate wells. hpi: hours post infection.
b. Homodimerization of IRF-3. Whole cell lysates prepared from cells that were mock-infected or had been infected with poliovirus for the indicated
amount of time or treated with poly(I:C) for 3.5 h were analyzed by native PAGE followed by immunoblot to detect IRF-3. The monomeric and
dimeric forms of IRF-3 are indicated
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Consequently, we examined MDA-5 and IPS-1 in infected
HEC-1B cells to determine if their proteolysis might ex-
plain the lack of IRF-3 activation. Analysis of steady state
levels of MDA-5 protein in infected HEC-1B cells shows
that even at 5 hpi very little cleavage of MDA-5 is detect-
able although it becomes more apparent at later times
(Fig. 6a, lanes 2–4). The presence of significant amounts of
intact MDA-5 protein at 4 hpi makes it seem unlikely that
cleavage of this protein contributes to the observed inhib-
ition of IRF-3 dimerization seen in infected cells at 3 and
4 hpi. A similar analysis of IPS-1 in poliovirus-infected
HEC-1B cells reveals very little evidence of proteolysis
even at 6 hpi (Fig. 6b, lane 4). These results indicate
that the inhibition of IRF-3 activation in poliovirus-
infected HEC-1B cells does not appear to be mediated
by the proteolytic cleavage of MDA-5 or IPS-1.
Fig. 6 Steady state levels of MDA-5 and IPS-1. Whole cell lysates prepared from cells that were mock-infected or had been infected with poliovirus for
the indicated amount of time were analyzed by immunoblotting with rabbit polyclonal antibodies that detect MDA-5 (a) or IPS-1 (b). The membrane
was stripped and reprobed with an antibody to β-actin to show equivalent loading of protein lysates. (*) indicates nonspecific band; Arrow indicates
cleavage product
Fig. 5 Poliovirus infection inhibits poly(I:C) induced IRF-3 activation. a. Experimental design. At zero hours cells were either mock infected or
infected with poliovirus at an MOI of 100 and at 1.5 h following infection or mock infection cells were either treated or not with poly(I:C). After
another 1.5 h/ 2.5 h lysates were harvested to extract protein. b. HEC-1B cells were either mock-infected or infected with poliovirus at an MOI of
100 and then treated with poly(I:C) or not for the indicated amount of time. Whole cell lysates were prepared in non-denaturing lysis buffer
and were analyzed by native PAGE followed by immunoblot to detect IRF-3. The monomeric and dimeric forms of IRF-3 are indicated. hpi: hours
post infection
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Discussion
This study has examined the induction of the type I
interferon response and the activation status of IRF-3,
NF-κB and ATF-2 in poliovirus-infected HEC-1B cells.
The results confirm that only very low levels of IFN-β
mRNA are induced following poliovirus infection and
suggest that the ability of infected cells to mount a type
I IFN response is impaired [18, 29]. Analysis of the tran-
scription factors required for induction of IFN-β mRNA
synthesis revealed that both NF-κB and ATF-2 were
present and activated in infected cells indicating that
HEC-1B cells can sense and respond to poliovirus-
associated molecular patterns. Despite this, IRF-3 is not
activated in poliovirus-infected cells as evidenced by the
lack of detectable levels of IRF-3 homodimer and tran-
scriptional induction from the ISG54 promoter. The
finding that poliovirus is able to inhibit poly(I:C) in-
duced IRF-3 homodimerization and IFN-β mRNA syn-
thesis indicates that poliovirus actively suppresses the
host response to dsRNA. Notably, inhibition occurs at a
time when IPS-1 and MDA-5 are not significantly de-
graded suggesting alternative mechanisms are respon-
sible for the blockade in IRF-3 activation seen in
poliovirus-infected cells.
Several picornaviruses are known to inhibit the type I
IFN response. HRV1a, coxsackievirus B3 and hepatitis A
virus have been shown to block the IRF-3 activation nor-
mally seen in cells infected with sendai virus [20, 21, 42]
and mengovirus infection blocks IRF-3 dimerization in
response to poly(I:C) [41]. In poliovirus-infected cells
MDA-5, RIG-I and IPS-1 are all cleaved by viral and/or
cellular proteases providing a potential mechanism for
inhibition of the type I IFN response [21, 23–25]. How-
ever, analysis of infected cells reveals that cleavage of these
proteins does not begin until 4 hpi or later [21, 24, 25].
The results presented here from HEC-1B cells are consist-
ent with these earlier findings and show that both IPS-1
and MDA-5 are mostly intact at 4 hpi. Significantly, cells
at this time are unable to mount a type I IFN response
when transfected with poly(I:C). Cumulatively, the results
suggest that poliovirus targets other factors in the type I
IFN response pathway to inhibit the synthesis of IFN- β
mRNA at early times post-infection.
Recognition of viral RNA by MDA-5 and signaling via
IPS-1 clearly plays an important role in host defense to
picornaviruses under certain conditions [9, 10, 13]. How-
ever, studies in transgenic animals expressing the polio-
virus receptor (PVR) suggest that other pathways are
crucial for protection from infection in vivo. These stud-
ies found that PVR-transgenic mice lacking MDA-5,
RIG-I or IPS-1 are no more susceptible to poliovirus-
induced disease than wild type mice [12, 13]. In contrast,
mice lacking TLR3 or the TLR3-specific adaptor mol-
ecule, Toll/IL-1R homology domain-containing adaptor
molecule 1 (TICAM-1, also known as TRIF) exhibited
increased mortality compared to wild-type littermates
when challenged with low infectious doses of poliovirus
[12]. These results suggest that recognition of poliovirus
by the TLR3 pathway is critical for protection from dis-
ease in vivo and suggest that it would be advantageous
for poliovirus to target components of the TLR3 path-
way to inhibit type I IFN synthesis. Evidence supporting
this possibility comes from studies in coxsackievirus-
infected cells showing that both RLR and TLR3 pathways
are compromised. Mukherjee et al., found that in CVB3-
infected HEK293 cells both IPS-1 and TICAM-1 are pro-
teolyzed [22]. Of note, this study found that cleavage of
TICAM-1 occurs earlier and is more extensive than that
of IPS-1 in CVB3-infected cells perhaps providing a clue
as to the relative or temporal importance of these path-
ways in controlling CVB3 infection. Similarly, enterovirus
68 infection inhibits the ability of HeLa cells to respond to
poly(I:C) and this is associated with cleavage of TICAM-1
and reduced IRF-3 activation [43]. Clearly experiments
examining the status of the TLR3 pathway in poliovirus-
infected cells are warranted.
The finding that NF-κB is activated in infected cells in-
dicates that the sensing and initial signaling response is
intact at least until the NF-κB and IRF-3 activation path-
ways diverge. Following activation of MDA-5 by dsRNA
it interacts with IPS-1 via common caspase activation
and recruitment domains (CARD) and promotes IPS-1
aggregation and activation on the mitochondrial mem-
brane [44]. Activated IPS-1 then serves as a platform for
recruitment of TRAF-6 and ultimately activation of the
NF-κB kinase complex IKKα/β and the IRF-3 kinases
TBK1 and IKK-ε [44]. Similarly, The TLR3 pathway, fol-
lowing the recruitment of TICAM-1/TRIF via common
Toll/IL-1 receptor (TIR) domains, leads to activation of
these same kinases [3]. Thus the TBK1 and IKK-ε ki-
nases responsible for the ultimate phosphorylation and
activation of IRF-3 and common to both pathways
would appear to be possible targets in poliovirus-
infected cells. Although analysis of CVB3-infected cells
indicate TBK1 is not activated or targeted for proteolysis
during infection with this enterovirus [23] the status of
TBK-1 or IKK-ε in poliovirus-infected cells has not been
examined.
Infection with many viruses, including poliovirus [45],
induces the formation of cytoplasmic structures called
stress granules (SG) that are composed of RNAs and
host RNA binding proteins and have been implicated in
the anti-viral response [46]. Although the mechanism by
which SGs inhibit viral replication is not entirely under-
stood recent reports indicate SGs may have a role in
modulating the type I IFN response. For example, the
NS1 protein of influenza is a potent inhibitor of the
type I IFN response and little IFN is produced, or SGs
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formed, in cells infected with wild type influenza [47].
However, in cells infected with a mutant influenza virus
lacking the NS1 protein strong induction of IFN-β mRNA
is seen along with SGs that contain RIG-I, MDA-5 and
IPS-1 [47]. Similarly, cells infected with encephalomyocar-
ditis virus (EMCV) or a mutant Theiler’s murine enceph-
alomyelitis virus that activates a type I IFN response also
caused SG formation along with recruitment of MDA-5 to
these structures [48, 49]. Notably, SG formation was
inhibited in cells lacking the dsRNA activated kinase, PKR
and PKR was also found to be recruited to SGs in infected
cells [47–49]. In the case of EMCV, influenza and cox-
sackievirus blocking SG formation during infection im-
pairs the ability of cells to induce IFN-β mRNA synthesis
[47, 49, 50]. These results directly link SG formation to ac-
tivation of the type I IFN response by certain viruses, in-
cluding picornaviruses, although one report indicates this
may not always be the case [48].
Both poliovirus and EMCV inhibit the anti-viral activ-
ities of SGs by proteolyzing the cellular RAS GAP SH3-
domain binding protein 1 (G3BP), a key component of
SGs [49, 51]. Consistent with the antiviral nature of SGs,
blocking the ability of poliovirus or EMCV to cleave
G3BP and inhibit SGs reduces virus yields obtained from
infected cells [49, 51]. Furthermore, blocking G3BP
cleavage in EMCV-infected HeLa cells allows SG forma-
tion and results in elevated levels of IFN- β [49]. Thus it
seems likely that modulation of SG nucleation and com-
position may contribute to the block in IRF-3 activation
and inhibition of the type I IFN response seen in
poliovirus-infected cells. While this may be the case,
additional experiments will be needed to determine if
G3BP cleavage and its effect on SG activity interferes
with IRF-3 activation and if so, how this occurs without
affecting activation of NF-κB and ATF-2.
Another intriguing possibility comes from work show-
ing that EV71 modulates the levels of TRAF6 and
IRAK1 during infection. TRAF6 is a ubiquitin ligase that
has an important role in signaling following TLR and
RLR engagement, while IRAK1 is involved primarily in
signaling from TLR7 and 9 [3, 44]. EV71 up regulates
expression of miR146a that, in turn, suppresses transla-
tion of IRAK1 and TRAF6 mRNAs [52]. Blocking the
action of miR146a restores levels of IRAK1 and TRAF6
in infected cells, increases IFN- β mRNA levels and im-
proves survival in a mouse model of EV71 pathogenesis
[52]. Cells infected with poliovirus and coxsackievirus
also show elevated levels of miR146a and reduced ex-
pression of IRAK1 and TRAF6 indicating they may em-
ploy a similar mechanism to impede type I IFN synthesis
[52]. While targeting TRAF6 and IRAK1 would interfere
with the Type I IFN response initiated by both RLR and
TLR signaling it would also be expected to inhibit NF-
kB activation. Thus, as is the case for SGs described
above, how miRNA-mediated inhibition of IRAK1 and
TRAF6 by poliovirus selectively interferes with IRF-3 ac-
tivation without impeding NF-κB or ATF-2 activation
remains to be determined.
Materials and methods
Cell culture and viruses
HEC-1B cells were grown in monolayer in Dulbecco’s
Modified Eagle’s Medium (DMEM) supplemented with
10 % Fetal Bovine Serum (FBS), 2 mM L-Glutamine and
Penicillin-Streptomycin at 37 °C in 5 % CO2. Mahoney
type I poliovirus (PV) stocks were prepared by infecting
sub-confluent HeLa monolayers at a multiplicity of in-
fection (MOI) of 10. Virus was adsorbed for 30 min at
37 °C in CPBS (phosphate-buffered saline (PBS) supple-
mented with 1 mM MgCl2 and 1 mM CaCl2). Following
adsorption, residual virus was removed and complete
medium was added. At 7 h post infection (hpi), cells
were scraped into CPBS, pelleted at 1500 × g, resus-
pended in CPBS and subjected to three freeze and thaw
cycles followed by centrifugation at 10,000 × g for five
minutes at 4 °C. The supernatant was titered on HeLa
cells, aliquoted and stored at −70 °C. Unless otherwise
indicated sub-confluent HEC-1B cells were infected with
poliovirus at an MOI of 50 as described above.
RNA isolation and cDNA synthesis
Mock and infected cells were incubated for the indicated
amounts of time and total RNA was prepared using the
Qiagen RNeasy mini kit (Qiagen; 74104). To remove any
traces of contaminating DNA, on column DNA diges-
tion was carried out using RNase-Free DNase kit
(Qiagen; 79254) as described by the manufacturer.
The quantity and purity of RNA was assessed using a
Nanodrop spectrophotometer (ND-1000). One micro-
gram of total RNA was reverse transcribed to cDNA
using the Superscript III First-Strand cDNA Synthesis
System for RT-PCR (Invitrogen; 18080–051). No-RT
controls were processed in the same way as cDNA
samples without the Superscript III enzyme.
Quantitative real-time PCR (qRT-PCR)
Either 0.2 or 0.4% of the total cDNA volume was used in
a SYBR green PCR assay (New England Biolabs; F-410 l).
PCR was performed on a 7500 Fast Real-Time PCR
System (Applied Biosystems). The PCR cycling condi-
tions were described previously [19]. The specificity of
amplification for each gene was confirmed by agarose
gel electrophoresis, melting curve analysis and sequen-
cing analysis. The cycle threshold (Ct) for each gene was
determined by setting the Ct line at the center of the
logarithmic phase of amplification for that particular
gene. The Ct differences between mock-infected and
virus-infected samples (analyzed in triplicate) were
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calculated using the delta delta Ct method [53]. Primer
sets used for the amplification of IFN-β, ISG54 and β-
actin were as previously described [19, 54].
Immunoblotting
HEC-1B cell lysates were prepared by scraping cells into
PBS followed by centrifugation at 200 × g for 5 min and
resuspended in Tx lysis buffer (50 mM triethanolamine
pH 7.4, 500 mM NaCl; 0.5 % Triton X-100; 1 mM di-
thiothreitol) containing 1X protease and phosphatase in-
hibitor cocktail (Calbiochem; 539134 and Sigma; P2850,
respectively). Following a 20 min incubation on ice ly-
sates were centrifuged at 16,000 g for 5 min and the pel-
let was discarded. Protein quantification was determined
using the Bio-Rad protein assay kit. Equal quantities of
protein were separated on SDS-8 % PAGE followed by
transfer to a PVDF membrane (Millipore Corporation).
Phosphorylated ATF-2 was detected using rabbit poly-
clonal and rabbit monoclonal antibodies, respectively (Cell
Signaling; #9221). Rabbit polyclonal antibodies were used
to detect IPS-1 (Axxora; ALX-210-929), MDA-5 (a kind
gift from Dr. Paul Fisher) [55], IRF-3 and NF-κB/p65
(Santa Cruz Biotechnology;sc-9082 and sc-109, respect-
ively) and β-actin (Abcam; ab8227). Antibody-antigen
complexes were detected using an HRP conjugated sec-
ondary antibody and chemiluminescence.
IRF-3 dimerization assay
Cell lysates were prepared by scraping cells into PBS
followed by centrifugation at 200 × g for 5 min and re-
suspension in native PAGE lysis buffer (50 mM Tris-Cl
pH 8.0, 150 mM NaCl and 1 % NP-40) containing 1X
protease and phosphatase inhibitor cocktail. Non-
denaturing 7.5 % acrylamide gels were pre-run at 40 mA
constant current for 30 min in cathode buffer (25 mM
Tris-Cl, 192 mM glycine and 0.2 % DOC, pH 8.4) and
anode buffer (25 mM Tris-Cl,192 mM glycine, pH 8.4)
at room temperature and equal quantities of proteins
were separated at 25 mA constant current for 50 min at
4 °C [40]. Proteins were transferred to PVDF membrane
at a constant current of 350 mA for one hour at 4 °C.
IRF-3 monomers and dimers were detected using an
anti-IRF-3 rabbit polyclonal antibody (Santa Cruz
Biotechnology: sc-9082) followed by an HRP conjugated
secondary antibody and chemiluminescence.
Immunofluorescence
HEC-1B cells were seeded onto 12 mm diameter cover-
slips and 48 h later cells were either mock-infected or
infected with poliovirus at an MOI of 50. Coverslips
were removed at the indicated times, fixed in 3 % for-
maldehyde for 15 min at 25 °C, washed three times in
PBS and permeabilized in methanol for 5 min at −20 °C.
Coverslips were then washed 3 times in PBS, incubated
in blocking solution (2 % BSA, 0.05 % Triton X-100 in
PBS) for 30 min at 25 °C and incubated overnight at
4 °C in primary antibody against NF-κB/p65 (Santa
Cruz Biotechnology: sc-109). Coverslips where then
washed three times in blocking solution, incubated
for 1 h at 25 °C in secondary antibody conjugated to
AlexaFluor 555 (Life Technologies), washed two times in
PBS, stained with Hoechst 33258 (0.2 μg/ml in PBS) and
mounted on glass slides with Vectashield mounting
medium (Vector laboratories; H-1000). Cells were viewed
on a Nikon E1000M fluorescent microscope at 60X mag-
nification and images were obtained using a Hamamatsu
Orca 285 digital monochrome camera and Metamorph
software (Universal Imaging).
Poly(I:C) treatment
HEC-1B cells were seeded in 35 mm wells and were ei-
ther mock-infected or infected with poliovirus at an
MOI of 100. After 1.5 h cells were transfected with
100 μg/ml of poly(I:C) (Sigma; P0913) using 800 μg/ml
of DEAE-dextran (Sigma; D9885) in serum free DMEM.
Mock-treated cells were exposed to DEAE-dextran in
the absence of poly(I:C). After an additional 1.5 or 2.5 h
incubation total RNA and protein lysates were prepared.
IFN-β mRNA levels and homodimerization of IRF-3
were quantified as described above.
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